Ad
related to: abbv).image- Our Science
See How We Impact Lives.
More Than Developing Medicines.
- Investor Resources
Find Financial Reports, Stock Info
And More Resources For Investors.
- AbbVie News Center
See Our Achievements, Growth Story,
and More Today.
- Read AbbVie Stories
Read Stories About Our Science,
People, and More Today.
- Our Science
Search results
AbbVie (ABBV) Gets FDA Rejection for Parkinson's Candidate
Zacks via Yahoo Finance· 1 year agoAbbVie ABBV announced that FDA has issued a complete response letter (CRL) to its new drug...
AbbVie (ABBV) to Boost Immunology Pipeline With New Acquisition
Zacks via Yahoo Finance· 2 years agoAbbVie Inc. ABBV recently announced that it has acquired UK-based private biotech, DJS Antibodies...
Can AbbVie (ABBV) Protect Revenues After Humira Patent Loss?
Zacks via Yahoo Finance· 9 months agoAbbVie’s ABBV key blockbuster immunology medicine, Humira lost patent protection in the United...
AbbVie (ABBV) Beats Q4 Earnings Estimates, Misses on Sales
Zacks via Yahoo Finance· 1 year agoAbbVie Inc. ABBV reported adjusted earnings of $3.60 per share for the fourth quarter of 2022,...
AbbVie (ABBV) to Report Q2 Earnings: What's in the Cards?
Zacks via Yahoo Finance· 2 years agoAbbVie's (ABBV) second-quarter results are expected to reflect the impact of strong demand for...
AbbVie (ABBV) to Acquire ImmunoGen (IMGN) for $10.1 Billion
Zacks via Yahoo Finance· 6 months agoAbbVie (ABBV) offers to buy ImmunoGen (IMGN) for approximately $10.1 billion, which will diversify...
Will AbbVie's (ABBV) New Drugs Continue to Drive Q4 Earnings?
Zacks via Yahoo Finance· 1 year agoAbbVie’s ABBV fourth-quarter revenues are likely to be driven by revenues generated from the sales...
AbbVie (ABBV), J&J to Withdraw 2 Blood Cancer Nods for Imbruvica
Zacks via Yahoo Finance· 1 year agoAbbVie (ABBV)/J&J's (JNJ) decision to withdraw the FDA's accelerated approval for Imbruvica in two...
Here's What's Driving AbbVie's (ABBV) Outperformance This Year
Zacks via Yahoo Finance· 2 years agoAbbVie (ABBV) boasts several new drugs with the potential to drive revenues once Humira loses U.S....
AbbVie (ABBV), J&J's Imbruvica Gets FDA Nod for cGVHD in Kids
Zacks via Yahoo Finance· 2 years agoAbbVie (ABBV) and J&J's (JNJ) Imbruvica gets FDA nod for label expansion to treat pediatric patients...
Ad
related to: abbv).image
